- Home
- FATE vs LFVN Comparison
FATE vs LFVN Comparison
Compare FATE & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FATE
- LFVN
- Stock Information
- Founded
- FATE 2007
- LFVN N/A
- Country
- FATE United States
- LFVN United States
- Employees
- FATE N/A
- LFVN N/A
- Industry
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- LFVN Biotechnology: Pharmaceutical Preparations
- Sector
- FATE Health Care
- LFVN Health Care
- Exchange
- FATE Nasdaq
- LFVN Nasdaq
- Market Cap
- FATE 177.7M
- LFVN 165.9M
- IPO Year
- FATE 2013
- LFVN N/A
- Fundamental
- Price
- FATE $1.14
- LFVN $12.01
- Analyst Decision
- FATE Hold
- LFVN Strong Buy
- Analyst Count
- FATE 7
- LFVN 2
- Target Price
- FATE $3.83
- LFVN $30.50
- AVG Volume (30 Days)
- FATE 1.7M
- LFVN 185.2K
- Earning Date
- FATE 08-12-2025
- LFVN 08-27-2025
- Dividend Yield
- FATE N/A
- LFVN 1.29%
- EPS Growth
- FATE N/A
- LFVN 152.87
- EPS
- FATE N/A
- LFVN 0.70
- Revenue
- FATE $13,335,000.00
- LFVN $222,347,000.00
- Revenue This Year
- FATE N/A
- LFVN $17.36
- Revenue Next Year
- FATE N/A
- LFVN $9.60
- P/E Ratio
- FATE N/A
- LFVN $17.14
- Revenue Growth
- FATE 105.85
- LFVN 8.22
- 52 Week Low
- FATE $0.66
- LFVN $5.76
- 52 Week High
- FATE $5.92
- LFVN $27.38
- Technical
- Relative Strength Index (RSI)
- FATE 46.69
- LFVN 40.54
- Support Level
- FATE $1.05
- LFVN $12.94
- Resistance Level
- FATE $1.18
- LFVN $14.62
- Average True Range (ATR)
- FATE 0.08
- LFVN 0.75
- MACD
- FATE -0.00
- LFVN -0.06
- Stochastic Oscillator
- FATE 54.76
- LFVN 16.37
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.